“hepatitis-c” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles 07/25/19 Boston
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Gilead Ups Stake in Galapagos With $5B Deal to Jumpstart Its R&D 07/15/19 San Francisco
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Vertex Continues Plan to Diversify, Strikes a $70M Pact With Kymera 05/15/19 Boston
Lilly to Launch “Authorized Generic” Insulin Priced at 50% Discount 03/04/19 Indiana
Gilead Sciences Commits $150M to Agenus in Cancer Drug R&D Pact 12/20/18 San Francisco
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Roche Vet O’Day Tapped to Shape Gilead’s Future as Hep C Sales Fall 12/10/18 San Francisco
Gilead to Make Generic Hepatitis C Drugs and Cut Prices Up to 75% 09/24/18 San Francisco
Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test 04/05/18 San Diego
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy 08/28/17 San Francisco
Report: Martin Shkreli Faces Prison Term After Fraud Conviction 08/04/17 New York
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall 06/12/17 San Diego
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug 01/06/17 National
Wake Up, Pharma—Trump Is Not Your Savior 12/08/16 Boston
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
How Doctors Think About Drug Prices 10/11/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
KaloBios Deals With Shkreli After Exiting Bankruptcy With New Cash 07/07/16 San Francisco
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
Page 1 of 10 next page »